Tuberc Respir Dis Search

CLOSE


Tuberc Respir Dis > Accepted Articles
DOI: https://doi.org/10.4046/trd.2020.0098    [Accepted]
Published online December 8, 2020.
Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients
Joon Young Choi, MD1, Wonjun Ji, MD, PhD2, Chang-Min Choi, MD, PhD2,3, Chaeuk Chung, MD, PhD4, Jae Myoung Noh, MD, PhD5, Cheol-Kyu Park, MD, PhD6,7, In-Jae Oh, MD, PhD6,7, Hong In Yoon, MD, PhD8, Hyeong Ryul Kim, MD, PhD9, Ho Young Kim, MD, PhD10, Chang Dong Yeo, MD, PhD11, Seung Hun Jang, MD, PhD12, on behalf of the Public Relation Committee of the Korean Association for Lung Cancer,
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
3Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
4Division of Pulmonology, Department of Internal Medicine, Chungnam National University, 282, Munhwaro, Jung‐gu, Daejeon, 35015, Republic of Korea
5Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea
6Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeollanam-do, 58128, Republic of Korea
7Department of Internal Medicine, Chonnam National University Medical School, 160 Baekseo-ro, Dong-gu, Gwangju, 61469, Republic of Korea
8Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
9Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
10Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 22 Gwanpyeong-ro 170 beon-gil, Dongan-gu, Anyang, Gyeonggi-do, 14068, Republic of Korea
11Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
12Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 22 Gwanpyeong-ro 170 beon-gil, Dongan-gu, Anyang, Gyeonggi-do, 14068, Republic of Korea
Correspondence:  Chang Dong Yeo, Tel: 82-2-2030-4310, Fax: 82-2-2030-2617, 
Email: brainyeo@catholic.ac.kr
Seung Hun Jang, Tel: 82-31-380-3718, Fax: 82-31-380-3973, 
Email: chestor@hallym.or.kr
Received: 3 September 2020   • Revised: 5 November 2020   • Accepted: 8 December 2020
Abstract
Background
Complementary and alternative medicine (CAM) has been frequently used and its use continues to increase in lung cancer patients, despite insufficient scientific evidence. We analyzed the current status of the awareness and use of CAM in Korean lung cancer patients.
Methods
This study was a prospective survey-based study performed at seven medical centers in South Korea between August 2019 and October 2019. The survey included general patient characteristics, and the awareness and use of CAM. We analyzed the differences in the clinical parameters between patients aware and not aware of CAM and between CAM non-users and users.
Results
A total of 434 patients were included in this study. Among them, 68.8% of the patients responded that they were aware of CAM, and 30.9% of the patients said they experienced CAM. In univariate analysis, patients aware of CAM were younger with poor performance status, patients with advanced-stage lung cancer, those who received more systemic therapy, and those who received CCRT. By multiple logistic regression, younger age, poor performance status, advanced stage, and prior CCRT were independent risk factors for CAM awareness. There were no significant differences in the general characteristics and cancer-associated clinical parameters between CAM non-users and users.
Conclusions
More lung cancer patients with younger age, poor performance status, advanced stage, and prior CCRT were aware of CAM. There were no significantly different characteristics between CAM users and non-users.
Key Words: Complementary therapies, Lung neoplasms, Awareness, Cross-sectional studies, Prospective studies


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2021 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2community

Close layer
prev next